Literature DB >> 14500669

The role of interleukin-10 in susceptibility of BALB/c mice to infection with Leishmania mexicana and Leishmania amazonensis.

Udaikumar M Padigel1, James Alexander, Jay P Farrell.   

Abstract

Recent studies have demonstrated the critical role of IL-10 in susceptibility to cutaneous and visceral leishmaniasis caused by Leishmania major and Leishmania donovani, respectively. To determine whether IL-10 also plays a similar role in the susceptibility and pathogenesis of cutaneous leishmaniasis caused by the New World species, L. mexicana and L. amazonensis, we analyzed their course of infection in IL-10-deficient BALB/c mice and their wild-type counterparts. Although IL-10-deficient mice infected with either L. mexicana or L. amazonensis failed to control the lesion progression, we did observe consistently lower levels of infection in IL-10(-/-) mice compared with wild-type BALB/c mice. We also observed increased IFN-gamma and NO production and higher levels for IL-12p40 and IL-12Rbeta(2) mRNA in cells from IL-10(-/-) mice compared with cells from BALB/c mice. The mRNA levels for IL-4, which increased significantly in both IL-10(-/-) and BALB/c mice, were comparable. When treated with anti-IL-4 mAb, IL-10(-/-) mice resolved the infection more effectively and had significantly fewer parasites in their lesions compared with similarly treated BALB/c mice. These findings suggest that IL-10, although not the dominant mediator of susceptibility of BALB/c mice to infection with L. mexicana and L. amazonensis, does play a significant role in regulating the development of a protective Th1-type response. However, effective resolution of infection with these New World parasites requires neutralization of both IL-4 and IL-10.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14500669     DOI: 10.4049/jimmunol.171.7.3705

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  35 in total

1.  Activation of the MAPK, ERK, following Leishmania amazonensis infection of macrophages.

Authors:  Ziyan Yang; David M Mosser; Xia Zhang
Journal:  J Immunol       Date:  2007-01-15       Impact factor: 5.422

2.  Heterologous prime-boost vaccination with the LACK antigen protects against murine visceral leishmaniasis.

Authors:  Blaise Dondji; Eva Pérez-Jimenez; Karen Goldsmith-Pestana; Mariano Esteban; Diane McMahon-Pratt
Journal:  Infect Immun       Date:  2005-08       Impact factor: 3.441

3.  NK cells in gamma-interferon-deficient mice suppress lung innate immunity against Mycoplasma spp.

Authors:  Matthew D Woolard; Dorothy Hudig; Leslie Tabor; James A Ivey; Jerry W Simecka
Journal:  Infect Immun       Date:  2005-10       Impact factor: 3.441

4.  GK1 Improves the Immune Response Induced by Dendritic Cells of BALB/c Mice Infected with Leishmania mexicana Promastigotes.

Authors:  Laila Gutiérrez-Kobeh; Arturo A Wilkins-Rodríguez
Journal:  Acta Parasitol       Date:  2019-09-30       Impact factor: 1.440

5.  THE MULTIFACETED ROLE OF T CELL-MEDIATED IMMUNITY IN PATHOGENESIS AND RESISTANCE TO MYCOPLASMA RESPIRATORY DISEASE.

Authors:  Nicole A Dobbs; Adam N Odeh; Xiangle Sun; Jerry W Simecka
Journal:  Curr Trends Immunol       Date:  2009

6.  Differential Regulation of l-Arginine Metabolism through Arginase 1 during Infection with Leishmania mexicana Isolates Obtained from Patients with Localized and Diffuse Cutaneous Leishmaniasis.

Authors:  Arturo A Wilkins-Rodríguez; Armando Pérez-Torres; Alma R Escalona-Montaño; Laila Gutiérrez-Kobeh
Journal:  Infect Immun       Date:  2020-06-22       Impact factor: 3.441

7.  Immunological determinants of clinical outcome in Peruvian patients with tegumentary leishmaniasis treated with pentavalent antimonials.

Authors:  Anne Maurer-Cecchini; Saskia Decuypere; François Chappuis; Coralie Alexandrenne; Simonne De Doncker; Marleen Boelaert; Jean-Claude Dujardin; Louis Loutan; Jean-Michel Dayer; Gianfranco Tulliano; Jorge Arevalo; Alexandro Llanos-Cuentas; Carlo Chizzolini
Journal:  Infect Immun       Date:  2009-02-23       Impact factor: 3.441

8.  Resistance of Leishmania (Viannia) braziliensis to nitric oxide: correlation with antimony therapy and TNF-alpha production.

Authors:  Anselmo S Souza; Angela Giudice; Júlia Mb Pereira; Luís H Guimarães; Amelia R de Jesus; Tatiana R de Moura; Mary E Wilson; Edgar M Carvalho; Roque P Almeida
Journal:  BMC Infect Dis       Date:  2010-07-15       Impact factor: 3.090

9.  Leishmania pifanoi proteoglycolipid complex P8 induces macrophage cytokine production through Toll-like receptor 4.

Authors:  Shanta M Whitaker; Maria Colmenares; Karen Goldsmith Pestana; Diane McMahon-Pratt
Journal:  Infect Immun       Date:  2008-02-25       Impact factor: 3.441

10.  N-acetyl-L: -cysteine reduces the parasitism of BALB/c mice infected with Leishmania amazonensis.

Authors:  Marta Chagas Monteiro; Fúlvia Carina Souza Marques; Renê Darela Blazius; Onilda Santos da Silva; Fernando de Queiroz Cunha; Diana Bittencourt Bento; Pedro Roosevelt Torres Romão
Journal:  Parasitol Res       Date:  2007-12-18       Impact factor: 2.289

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.